An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

Decades ago, the FDA approved the use of two prescription medicines — mifepristone and misoprostol — to terminate ... performed each month in states that either ban abortion totally or after six weeks ...

Over the years, the FDA has removed some restrictions on mifepristone. In 2016, it extended its use from seven to 10 weeks into pregnancy. In 2019, it approved a generic version of the medication.

For those unfamiliar with the medication, the FDA approved mifepristone about a quarter of a century ago, to be used as part of a two-step process to terminate unwanted pregnancies up to 10 weeks.

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues … ...

FDA Commissioner Marty Makary wrote a letter to pro-life Senator Josh Hawley (R., Mo.) Monday informing him of the agency’s plan to conduct a review of mifepristone.

This analysis of 865,727 women who had been prescribed mifepristone, the first pill of the chemical abortive cocktail, showed they were 22 times more likely to experience a medical emergency or ...

This was bound to happen. After all, mifepristone has been embroiled in controversy for 25 years. The FDA approved its marketing and use in 2000, but only under unusual circumstances.

The FDA approved mifepristone in 2000 as a safe and effective way to end early pregnancies. Currently, there are no in-person requirements and the pill can be sent through the mail.